Results 91 to 100 of about 28,403 (261)
São Paulo Medical JournalCONTEXT AND OBJECTIVE: According to some cohort studies, the prevalence of refractory schizophrenia (RS) is 20-40%. Our aim was to evaluate the effectiveness and safety of aripiprazole, paliperidone, quetiapine and risperidone for treating RS.
Tamara Melnik +3 more
doaj +1 more source
Comparative Clinical Trajectories Across Cannabis‐Related and Nonsubstance‐Related Psychoses
Acta Psychiatrica Scandinavica, EarlyView.ABSTRACT Background Research indicates that first‐episode psychosis (FEP) with cannabis use disorder (CUD) carries a substantial disease burden, but more granular clinical trajectories of cannabis‐related psychoses remain unclear. This study examines the clinical trajectories of first clinically diagnosed FEP&CUD and cannabis‐induced psychosis (CIP) in
Antti Mustonen +7 more
wiley +1 more source
Antipsychotic medication for people with first episode schizophrenia: an exploratory economic analysis of alternative treatment algorithms [PDF]
Available clinical evidence suggests that the newer antipsychotics are similar to conventional antipsychotics for positive symptom control. It has been suggested that they may also be superior for negative symptoms and side effects, but the evidence for ...
Linda Davies, Shon Lewis
core
Tardive dyskinesia with atypical antipsychotics in youth
, 2022 Tardive dyskinesia with atypical antipsychotics in ...
P Burnett (13346730) +1 more
core
A call for action: Closing the evidence gap in management of stimulant‐induced psychosis
Addiction, EarlyView.Abstract Background Stimulant‐induced psychosis (StIP) is emerging as one of most pressing health challenges. Over the past two decades, stimulant‐related harms and psychiatric care demands have risen sharply. Individuals with StIP often present with severe agitation and high suicide risk, and up to half progress to chronic psychotic illness within two
Anne Bouthillier +3 more
wiley +1 more source
JRSM Open, 2018 Objective This study aims to assess the current antipsychotic prescribing trends for the treatment of schizophrenia and to compare them with available guidelines and research evidence. Design An observational retrospective quantitative analysis.
Rossela Roberts +3 more
doaj +1 more source
Addiction, EarlyView.Abstract Aim Our primary aim was to conduct a network meta‐analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharmacotherapies for cannabis use disorder (CUD). Methods We conducted a NMA of studies identified from two completed systematic reviews examining the effectiveness, safety and ...
Monika Halicka +6 more
wiley +1 more source
Typical and Atypical Antipsychotics in Acute Mania: Comparison of Effectiveness
, 2017 IntroductionMania is challenging to treat. Typical antipsychotics may be more efficient compared with atypical antipsychotics, however, with unfavourable side effects.ObjectivesTo help the clinician choose between typical and atypical antipsychotics ...
L.M. Kai +4 more
core +1 more source
Risk factors for pneumonia in patients with schizophrenia
Neuropsychopharmacology Reports, 2018 Aim Pneumonia is a major cause of death in patients with schizophrenia. Preventive strategies based on identifying the risk factors are needed to reduce pneumonia‐related mortality.
Takahiro Haga +5 more
doaj +1 more source
Sleep Disorders in Klinefelter Syndrome and Other Sex Chromosome Aneuploidies: A Narrative Review
Andrology, EarlyView.ABSTRACT Background Sex chromosome aneuploidies (SCAs) are among the most frequent types of chromosomal aneuploidies and include Klinefelter syndrome (47,XXY and higher‐grade variants), 47,XYY syndrome, Turner syndrome (45,X), and trisomy X (47,XXX).
Roberto Paparella +3 more
wiley +1 more source